Kewaunee Scientific Q1 FY2023 net loss narrows to $0.27/share; sales up 27% YoY

KEWAUNEE SCIENTIFIC CORP /DE/

2023-Q1 EPS reported -$0.27 revenue$50,123,000

Sales $50.1M, up 26.9% YoY from $39.5M; net loss of $747K vs $1.35M loss a year earlier.
Diluted EPS loss $0.27 vs loss $0.48; EBITDA improved to $275K from -$342K.
Order backlog $174M, a record for fourth time in five quarters, up from $120.6M a year ago.
Domestic segment swung to net income of $98K from loss; International net income rose to $687K.
Cash $21.5M; no short-term debt; long-term debt $29.5M; debt-to-equity 1.09-to-1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.